Stock market experts recommended five stocks for trade on Tuesday that promise returns for investors. Somil Mehta, Head Alternate Research, Mirae Asset Sharekhan, suggests buying Glenmark Pharmaceuticals Ltd. at the current market level with a target price of Rs 2,040 and a stop loss at Rs 1,925.
Out of 11 analysts tracking the company, nine maintain a 'buy' rating, one recommend a 'hold,' and one suggests 'sell,' according to Bloomberg data. The average 12-month consensus price target implies an upside of 11.8%
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
Another stock that Mehta suggests is Bharti Airtel Ltd. at the current market level with a target price of Rs 2,020 and a stop loss at Rs 1,895. Out of 33 analysts tracking the company, 26 maintain a 'buy' rating, three recommend a 'hold,' and four suggest 'sell,' according to Bloomberg data. The average 12-month consensus price target implies an upside of 8.9%
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
Vaishali Parekh, Vice President, Technical Research, Prabhudas Lilladher Pvt. Ltd, recommends buying Gufic BioSciences Ltd. at the current market level with a target price of Rs 400 and a stop loss at Rs 365.
He also suggests buying IRB Infrastructure Developers Ltd. at the current market level with a target price of Rs 48 and a stop loss at Rs 43. Out of seven analysts tracking the company, four maintain a 'buy' rating and three recommend a 'hold,' according to Bloomberg data.
The average 12-month consensus price target implies a downside of 35.4%. His third recommendation is, Advanced Enzyme Technologies Ltd. at the current market level with a target price of Rs 330 and a stop loss at Rs 310.
Only one analyst is tracking the company, and they maintain a 'buy' rating on the stock. The average 12-month consensus price target implies an upside of 42.3%
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
